These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 16434416)

  • 1. Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease.
    Koga H; Sugiyama S; Kugiyama K; Fukushima H; Watanabe K; Sakamoto T; Yoshimura M; Jinnouchi H; Ogawa H
    Eur Heart J; 2006 Apr; 27(7):817-23. PubMed ID: 16434416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
    Tan KT; Tayebjee MH; Lim HS; Lip GY
    Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease.
    Koga H; Sugiyama S; Kugiyama K; Watanabe K; Fukushima H; Tanaka T; Sakamoto T; Yoshimura M; Jinnouchi H; Ogawa H
    J Am Coll Cardiol; 2005 May; 45(10):1622-30. PubMed ID: 15893178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum amyloid A, C-reactive protein and remnant-like lipoprotein particle cholesterol in type 2 diabetic patients with coronary heart disease.
    Hamano M; Saito M; Eto M; Nishimatsu S; Suda H; Matsuda M; Matsuki M; Yamamoto S; Kaku K
    Ann Clin Biochem; 2004 Mar; 41(Pt 2):125-9. PubMed ID: 15025802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
    Habib SS; Aslam M; Naveed AK; Razi MS
    Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelium and inflammatory process, in patients with combined Type 2 diabetes mellitus and coronary atherosclerosis: the effects of vitamin C.
    Antoniades C; Tousoulis D; Tountas C; Tentolouris C; Toutouza M; Vasiliadou C; Tsioufis C; Toutouzas P; Stefanadis C
    Diabet Med; 2004 Jun; 21(6):552-8. PubMed ID: 15154938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients.
    Kobayashi J; Nakajima K; Nohara A; Kawashiri M; Yagi K; Inazu A; Koizumi J; Yamagishi M; Mabuchi H
    Horm Metab Res; 2007 Aug; 39(8):612-6. PubMed ID: 17712727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of high remnant-like lipoproteins on the function of peripheral arterial endothelium in patients with hyperlipidemia and normolipidemia: estimation using Doppler flow analysis].
    Funada J; Sekiya M; Otani T; Watanabe K; Akutsu H
    J Cardiol; 2001 May; 37(5):267-76. PubMed ID: 11392896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus.
    Omoto S; Nomura S; Shouzu A; Nishikawa M; Fukuhara S; Iwasaka T
    Diabetologia; 2002 Apr; 45(4):550-5. PubMed ID: 12032632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of decreased serum adiponectin for type IIb hyperlipidaemia and increased cholesterol levels of very-low-density lipoprotein in type II diabetic patients.
    Yoshida H; Hirowatari Y; Kurosawa H; Tada N
    Clin Sci (Lond); 2005 Sep; 109(3):297-302. PubMed ID: 15907189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of eicosapentaenoic acids on remnant-like particles, cholesterol concentrations and plasma fatty acid composition in patients with diabetes mellitus.
    Nakamura N; Hamazaki T; Kobayashi M; Ohta M; Okuda K
    In Vivo; 1998; 12(3):311-4. PubMed ID: 9706476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remnant-like lipoprotein particles as risk factors for coronary artery disease in elderly patients.
    Inoue T; Uchida T; Kamishirado H; Takayanagi K; Hayashi T; Morooka S; Saniabadi AR; Nakajima K
    Horm Metab Res; 2004 May; 36(5):298-302. PubMed ID: 15156409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low HDL-cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan-European survey.
    Bruckert E; Baccara-Dinet M; Eschwege E
    Diabet Med; 2007 Apr; 24(4):388-91. PubMed ID: 17335463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remnant-like lipoprotein particle level and insulin resistance are associated with in-stent restenosis in patients with stable angina.
    Kato T; Inoue T; Inagaki H; Hashimoto S; Hikichi Y; Tanaka A; Isobe M; Node K
    Coron Artery Dis; 2007 Jun; 18(4):319-22. PubMed ID: 17496497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease.
    Tenenbaum A; Motro M; Fisman EZ; Schwammenthal E; Adler Y; Goldenberg I; Leor J; Boyko V; Mandelzweig L; Behar S
    Circulation; 2004 May; 109(18):2197-202. PubMed ID: 15123532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipids in type 2 diabetes.
    Laakso M
    Semin Vasc Med; 2002 Feb; 2(1):59-66. PubMed ID: 16222596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pioglitazone on atherogenic outcomes in type 2 diabetic patients: a comparison of responders and non-responders.
    Igarashi M; Jimbu Y; Kimura M; Hirata A; Yamaguchi H; Tominaga M
    Diabetes Res Clin Pract; 2007 Sep; 77(3):389-98. PubMed ID: 17275945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation and association between plasma platelet-, monocyte- and endothelial cell-derived microparticles in hypertensive patients with type 2 diabetes mellitus.
    Nomura S; Inami N; Shouzu A; Urase F; Maeda Y
    Platelets; 2009 Sep; 20(6):406-14. PubMed ID: 19658004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidant status and lipid peroxidation end products in patients of type 1 diabetes mellitus.
    Peerapatdit T; Likidlilid A; Patchanans N; Somkasetrin A
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S141-6. PubMed ID: 17718255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the PPARalpha L162V polymorphism, plasma lipoprotein levels, and atherosclerotic disease in patients with diabetes mellitus type 2 and in nondiabetic controls.
    Gouni-Berthold I; Giannakidou E; Müller-Wieland D; Faust M; Kotzka J; Berthold HK; Krone W
    Am Heart J; 2004 Jun; 147(6):1117-24. PubMed ID: 15199365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.